ClinicalTrials.gg
RecruitingNCT07520734LHPUpdated Jul 9, 2026

Clinical Outcomes After Laser Hemorrhoidoplasty

An observational study in Hemorrhoidal Disease and Internal Hemorrhoids, sponsored by Sanliurfa Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by Sanliurfa Education and Research Hospital · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
60
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 131 studies in Patient Satisfaction with a site in Turkey — 32 open to participants now, 33 under way, none of them phase 3. Patient Satisfaction · Turkey.

Planned enrollment
22nd of 29
60 · median 120
Started
2026
with 28 others
Observational
29 of 131
6 open now
Primary completion
2027-01
later than 19 of 32 live
Registered
107th of 131
by date

Among the 131 studies in Patient Satisfaction with a site in Turkey, this one is the 22nd largest by planned enrollment of the 29 observational ones that give a count, is one of 29 that started in 2026, is one of 29 observational ones, reaches primary completion later than 19 of the 32 other live ones, and was the 107th registered.

Patient Satisfaction

882 studies on the registry are indexed under Patient Satisfaction; 205 are open to participants now.

Browse Patient Satisfaction studies →

Open to participants now

32 of the 131 studies in Patient Satisfaction with a site in Turkey are open now. Recruiting first, the newest first:

26 more — sign in →

All 32 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 102 Patient Satisfaction studies recruiting now, 63 (62%) set no upper age limit and 31 (30%) stop at 75 or younger; 14 take children under 18; 26 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 131 studies in Patient Satisfaction with a site in Turkey, or all of them as a file.
02

Study summary

This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.

Read the detailed description

Hemorrhoidal disease is a common benign anorectal condition that can significantly impair quality of life. Conventional excisional techniques may be associated with postoperative pain, bleeding, prolonged recovery, and lower patient satisfaction. Laser hemorrhoidoplasty is a minimally invasive technique based on coagulation and shrinkage of hemorrhoidal tissue without excision. This prospective observational study will be conducted at the General Surgery Clinic of Sanliurfa Education and Research Hospital. Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty will be enrolled. Preoperative symptoms, hemorrhoid stage, and physical examination findings will be recorded. Intraoperative data will include laser wavelength, total delivered energy, number of hemorrhoidal packages treated, and any additional surgical procedures. Postoperative pain will be assessed at predefined time points using the Visual Analog Scale. Analgesic requirement and duration, length of hospital stay, time to return to daily activities, early complications within 30 days, late complications, symptom status, and recurrence at 6 months will be documented. The study is designed to clarify the clinical role of laser hemorrhoidoplasty and help define appropriate patient selection criteria.

03

Conditions studied

  • Hemorrhoidal Disease
  • Internal Hemorrhoids

Browse trials for

Keywords

  • Laser hemorrhoidoplasty
  • Hemorrhoidal disease
  • Patient satisfaction
  • Visual Analog Scale
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty at the General Surgery Clinic of Sanliurfa Education and Research Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Symptomatic internal hemorrhoidal disease
  • Scheduled to undergo laser hemorrhoidoplasty
  • Willingness to participate and provision of

Exclusion criteria

Exclusion Criteria:

  • Grade IV hemorrhoidal disease
  • Acute thrombosed hemorrhoids
  • Additional anorectal pathology such as anal fissure, fistula, or perianal abscess
  • History of inflammatory bowel disease or colorectal
  • Previous major anal surgery'
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients undergoing laser hemorrhoidoplasty

    Adults with symptomatic internal hemorrhoidal disease undergoing laser hemorrhoidoplasty.

    Procedure: Laser Hemorrhoidoplasty

Interventions

  • ProcedureLaser Hemorrhoidoplasty

    Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.

06

What researchers measure

Primary outcomes

  1. Postoperative pain score

    Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.

    Time frame: At 6 hours, 24 hours, and 1 week after surgery

Secondary outcomes

  1. Duration of postoperative analgesic use

    Duration of postoperative analgesic use, measured in days.

    Time frame: From the day of surgery through 30 days after surgery

  2. Length of hospital stay

    Postoperative hospital stay, measured in days from the date of surgery to the date of discharge.

    Time frame: From the day of surgery to hospital discharge, up to 7 days

  3. Incidence of predefined early postoperative complications

    Number and proportion of patients who develop any predefined early postoperative complication within 30 days after laser hemorrhoidoplasty. Predefined complications include postoperative bleeding, urinary retention, anal thrombosis, infection, severe pain, and anal stenosis. Patients without any of these events will be classified as having no complication.

    Time frame: Within 30 days after surgery

  4. Time to return to daily activities

    Time required to return to usual daily activities, measured in days.

    Time frame: Up to 30 days after surgery

  5. Patient satisfaction

    Patient-reported satisfaction after laser hemorrhoidoplasty.

    Time frame: Up to 3 months after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because this is a single-center study involving sensitive patient-level clinical data, and there is no pre-specified institutional mechanism for external data sharing. Only aggregated, de-identified study results will be reported.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Jan 2027, 7 months after the start.

Of 107 non-industry observational studies under Patient Satisfaction, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 45. This study's planned 7 months is below that.

Counting every sponsor, half of 113 studies reached it within 20 months; a quarter within 7 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 24, 2026
First posted
Apr 9, 2026
StartActual
Jun 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Apr 1, 2027
Last update
Jul 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07520734
Lead sponsor
Sanliurfa Education and Research Hospital
Responsible party
Vedat Kaplan (General Surgery Specialist, Sanliurfa Education and Research Hospital) — Principal investigator
First posted
Apr 9, 2026
Start date
Jun 1, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Jul 9, 2026

Study contacts

Vedat Kaplan, MD
Contact
vedat_kaplan_@hotmail.com
+905459045165
Vedat Kaplan
principal investigator · Sanliurfa Education and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion